Trial Profile
Effects of LMWH Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Enoxaparin sodium
- Indications Stroke; Thromboembolism; Venous thromboembolism
- Focus Pharmacodynamics
- 28 Apr 2016 Study design changed from randomised,cross over to Non-randomised and single group also dosage of study drugs modified
- 15 Dec 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 24 Mar 2015 New trial record